Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Conditions
- GlioblastomaRecurrent GlioblastomaGBM
- Interventions
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- CarThera
- Target Recruit Count
- 560
- Registration Number
- NCT05902169
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸UCHealth, Aurora, Colorado, United States
Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- CarThera
- Target Recruit Count
- 38
- Registration Number
- NCT03744026
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
🇫🇷CHU, Angers, France
News
Carthera's SonoCloud System Receives EMA Orphan Medical Device Endorsement for Brain Tumor Treatment
Carthera has received EMA expert panel endorsement for Orphan Medical Device status of its SonoCloud ultrasound system, making it one of the first companies to benefit from this new EU pilot program.
Carthera Enrolls 100 Patients in Landmark SONOBIRD Trial Using Ultrasound to Breach Blood-Brain Barrier in Glioblastoma
Carthera has reached a significant milestone in its SONOBIRD pivotal trial, enrolling 100 patients with recurrent glioblastoma across 40 sites in Europe and the US.